Coronary vasorelaxation by nitroglycerin: Involvement of plasmalemmal calcium-activated K+ channels and intracellular Ca++ stores

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 3, 1998, Pages 838-846

  Khan, Sajida A ^a   Higdon, Nicole R ^a   Meisheri, Kaushik D ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [1 (3 CHLOROPHENYL)CYCLOBUTYL] 2 CYANO 3 (3 PYRIDYL)GUANIDINE; 2 CYANO 1 (1,1 DIMETHYLPROPYL) 3 (3 PYRIDYL)GUANIDINE; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; CHARYBDOTOXIN; CORONARY VASODILATING AGENT; GLYCERYL TRINITRATE; IBERIOTOXIN; N (1 ADAMANTYL) N' CYCLOHEXYL 4 MORPHOLINECARBOXAMIDINE; NITRIC OXIDE; PNU 46619; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHLORIDE; POTASSIUM ION; RYANODINE; THAPSIGARGIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DOG; DRUG MECHANISM; MALE; MESENTERIC ARTERY; MESENTERIC VEIN; NONHUMAN; PRIORITY JOURNAL; SAPHENOUS VEIN; SARCOPLASMIC RETICULUM;

ANIMALS; CALCIUM; CHARYBDOTOXIN; CORONARY VESSELS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NITROGLYCERIN; PEPTIDES; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RYANODINE; THAPSIGARGIN; VASODILATION; VASODILATOR AGENTS;

EID: 0031935106     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. 2+ antagonists. J Cardiovasc Pharmacol 6(4):S630-S638.
2. Cornwell TL, Pryzwansky KB, Wyatt TA and Lincoln TM (1991) Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells. Mol Pharmacol 40:923-931.
3. Garcia ML, Galvez A, Garcia-Galvo M, King VF, Vazque J and Kaczorowski GJ (1991) Use of toxins to study potassium channels. J Bioenerg Biomemb 23:615-646.
4. 2+ stores in sarcoplasmic and endoplasmic reticulum. Science 275:1643-1648.
5. + channel in the relaxation of bovine tracheal smooth muscle by glyceryl trinitrate and sodium nitroprusside. J Pharmacol Exp Ther 262:263-270.
6. He G, Yang C, Gately H, Furnary A, Swanson J, Ahmad A, Floten S, Wood J and Starr A (1996) Potential greater than additive vasorelaxant actions of milrinone and nitroglycerin on human conduit arteries. Br J Clin Pharmacol 41:101-107.
7. 2+ entry in rabbit aorta. J Pharmacol Exp Ther 233:100-111.
8. ATP opener vasodilator. J Pharmacol Exp Ther 2803:255-260.
9. Hirata M, Kohse KP, Chang C, Ikebe T and Murad F (1990) Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J Biol Chem 265:1266-1273.
10. Ignarro LJ and Kadowitz PJ (1985) The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol 25:171-191.
11. Karaki H, Murakami K and Urakawa N (1986) Mechanism of inhibitory action of sodium nitroprusside in vascular smooth muscle of rabbit aorta. Arch Int Pharmacodyn 280:230-240.
12. + channels in vasodilation induced by nitroglycerine, acetylcholine and nitric oxide. J Pharmacol Exp Ther 267:1327-1335.
13. ATP blockers. J Pharmacol Exp Ther 283:1207-1213.
14. Lincoln TM (1989) Cyclic GMP and mechanisms of vasodilation. Pharmacol Ther 41:479-502.
15. Lincoln TM and Cornwell TL (1991) Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation. Blood Vessels 28:129-137.
16. Lincoln TM and Cornwell TL (1993) Intracellular cyclic GMP receptor proteins. FASEB J 7:328-338.
17. ++ pool in vascular smooth muscle. J Pharmacol Exp Ther 258:1105-1113.
18. Mackenzie JE and Parratt JR (1977) Comparative effects of glyceryl trinitrate on venous and arterial smooth muscle in vitro; relevance to antianginal activity. Br J Pharmacol 60:155-160.
19. 2+ release in smooth muscle. Am J Physiol 250:C171-C174.
20. + channel-dependent and cyclic GMP-dependent components in a single vascular preparation. J Cardiovasc Pharmacol 17:903-912.
21. + channel openers. J Vasc Res 30:2-12.
22. Miwa K and Toda N (1985) The regional differences of relaxations induced by various vasodilators in isolated dog coronary and mesenteric arteries. Jpn J Pharmacol 38:313-320.
23. Sturek M, Kunda K and Hu Q (1992) Sarcoplasmic reticulum buffering of myoplasmic calcium in bovine coronary smooth muscle. J Physiol 45:25-48.
24. + channels are stimulated by cyclic guanosine monophosphate-dependent protein kinase in canine coronary artery smooth muscle cells. Pflugers Arch 423:167-172.
25. Tare M, Parkington HC, Coleman HA, Neild TO and Dusting GJ (1990) Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature (Lond) 346:69-71.
26. 45Ca fluxes in vascular smooth muscle. J Pharmacol Exp Ther 237:803-808.
27. 2+-ATPase. Proc Natl Acad Scii USA 87:2466-2470.
28. Van Breemen C, Chen Q and Laher I (1995) Superficial buffer barrier function of smooth muscle sarcoplasmic reticulum. Trends Pharmacol Sci 16:98-105.
29. 2+ in smooth muscle cells from bovine and porcine coronary artery: modulation of sarcoplasmic reticulum function. Br J Pharmacol 105:903-911.
30. Wei JY and Reid PR (1979) Quantitative determination of trinitroglycerin in human plasma. Circulation 59:588-592.
31. 2+ pump ATPase of vascular smooth muscle via phosphorylation of a 240-kDa protein. J Biol Chem 266:19819-19827.